These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27538952)

  • 21. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
    Ye P; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Am Geriatr Soc; 2007 Jul; 55(7):1015-22. PubMed ID: 17608873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial.
    Wang S; Jiang H; Yu Q; She B; Mao B
    Trials; 2017 Jan; 18(1):2. PubMed ID: 28057058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guanxinjing capsule in the treatment of chronic stable angina: study protocol for a randomized controlled trial.
    Tian Y; Zhang J; Zhao Y; Mao J; Zhu L; Gao R; Wang X; Zhu M; Ma L; Zhao M; Zheng W
    Trials; 2018 Oct; 19(1):577. PubMed ID: 30342551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trial.
    Jiang Y; Guo H; Liu Y; Wang X; Liang J; Xi R; Bai R; Shi D
    Trials; 2019 Apr; 20(1):218. PubMed ID: 30987658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and safety of Chinese herbal medicine xuanbi antong granules for the treatment of borderline coronary lesions: study protocol for a randomised, double-blinded, placebo-controlled, multicentre clinical trial.
    Huang M; Chen G; Guan Q; Liu C; Zhao Q; Li J; Yao K; Zhang Z; He H; Li Y; Lin F; He X; Liu Y; Xiong XJ; Zhang Y; Han M; Wang J
    BMJ Open; 2019 Aug; 9(8):e024968. PubMed ID: 31399446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial.
    Huang Z; Zhuang X; Zhang S; Huang Y; Yuan L; Lin A; Tang L; Xiong Z; Christopher O; Chen Y; Wu B; Ling Y; Li S; Jie Q; Xiong L; Qian X; Liao X; Liu J
    BMJ Open; 2023 Jul; 13(7):e072541. PubMed ID: 37433737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Ruan X; Li Y; Sun Y; Jia M; Xu X; Huo L; Song W; Yao Y; Wang X
    Trials; 2021 Jul; 22(1):466. PubMed ID: 34281600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial.
    Zhang X; Tian G; Shi Z; Sun Y; Hu J; Jiang Y; Zheng R; Chen S; Li C; Yang X; He T; Han S; Zhang C; Zhang L; Liu Y; Shang H;
    Trials; 2020 Jan; 21(1):48. PubMed ID: 31915046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis.
    Zhu Z; Wang Y; Liao W; Li H; Wang D
    Medicine (Baltimore); 2018 Jun; 97(24):e11062. PubMed ID: 29901609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
    Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
    Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naoxuekang, Xinnaoshutong and Xuesaitong capsules for treating stroke: a protocol for a randomised controlled trial.
    Chen H; Cao H; Guo X; Zhao M; Xia Q; Chen B; Zhao T; Gao W
    BMJ Open; 2017 Nov; 7(11):e015983. PubMed ID: 29122785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
    Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
    Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.
    Gan J; Wu Y; Gong X; Ma Y; Yu S; Gao J
    Trials; 2019 Aug; 20(1):481. PubMed ID: 31391092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Dai L; Zhong LL; Cao Y; Chen W; Cheng Y; Lin XF; Bian ZX; Lu AP
    Trials; 2016 Jun; 17(1):291. PubMed ID: 27316679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity.
    Zhang L; Li Y; Yang BS; Li L; Wang XZ; Ge ML; Jing QM; Ma YY; Wang G; Liu HW; Zhao X; Wang B; Xu K; Han YL
    Chin Med J (Engl); 2018 Mar; 131(5):508-515. PubMed ID: 29483383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.